Alterity Therapeutics’ phase II study of its lead compound ATH434 in multiple system atrophy (MSA) has been featured in an oral presentation at the American Autonomic Society (AAS) 36th International ...

Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today ...

Alterity Therapeutics has announced a series of board changes ahead of its AGM today, positioning the biotech for its next ...

Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today ...

Alterity Therapeutics ( ($AU:ATH) ) has shared an update. Alterity Therapeutics announced significant progress at its 2025 Annual General Meeting, ...

Detailed price information for Alterity Therapeutics Limited (PRNAF) from The Globe and Mail including charting and trades.

In an exclusive interview, Alterity Therapeutics’ ( ATHE) CEO David Stamler met with The Fly to discuss the company, the biotech industry, ongoing trials, upcoming milestones and much more. Published ...

The ASX inched higher at lunch as miners did the heavy lifting, and MinRes stole the show with a billion-dollar lithium deal ...

Novartis plans to upfit a 202,000-square-foot purpose-built space in Pathway Triangle, a new advanced manufacturing campus in ...

The α-synuclein protein can adopt several different conformations that cause neurodegeneration. Different α-synuclein conformers cause at least three distinct α-synucleinopathies: multiple system ...

Rohit Sharma achieved his 50th international century, a milestone only two other Indians have reached. He scored 121* against Australia in Sydney, topping the series with 202 runs and earning Player ...

Australia's democratic system is unlike any other on Earth. As a nation, we sort of vaguely understand this, and take a generalised pride in the triennial democracy sausage, and the beige, competent ...